Atopic

Wilmington, Delaware, United States, July 31, 2023 (GLOBE NEWSWIRE) -- The global atopic dermatitis drugs market stood at US$ 6.0 billion in 2021, and the global market is projected to…

SAN MATEO, Calif. and SINGAPORE, July 05, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing…

"Medical Journeys" is a set of clinical resources reviewed…

SAN MATEO, Calif. and SINGAPORE, June 23, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing…

Lori Solomon WEDNESDAY, May 31, 2023 (HealthDay News) -- Atopic dermatitis (AD) in adulthood is associated with an increased risk for venous…

Ongoing phase 1b trial is designed to evaluate safety, tolerability, and efficacy of si-544 in T-cell mediated autoimmunity Dosing of MAD stage has been initiated; first results expected…

<!-- Name:DistributionId Value:8832285 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True -->…

<!-- Name:DistributionId Value:8824587 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

Elana Gotkine MONDAY, March 27, 2023 (HealthDay News) -- Adults with atopic dermatitis (AD) have an increased risk for developing melanoma, basal cell…

While it's well-established that atopic dermatitis (AD) can be associated with various allergic comorbidities -- including…